What is TVTX's P/E ratio?

TRAVERE THERAPEUTICS INC (TVTX) currently trades at a P/E ratio of 140.49.

TRAVERE THERAPEUTICS INC reports a Return on Equity (ROE) of -21.70%.

What is TVTX's dividend yield?

TRAVERE THERAPEUTICS INC offers a dividend yield of 0.00%.

What is TVTX's Deepscope Quality Score?

Deepscope rates TVTX's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy TVTX?

Deepscope's AI Timing Score for TVTX is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does TVTX belong to?

TRAVERE THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

หุ้น TVTX (NASDAQ) | TRAVERE THERAPEUTICS INC – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-03 | FS: 2026-03-31)

TVTX

TRAVERE THERAPEUTICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 85

USD 45.20

2.24 (5.21%) Day Change

Watchlist Portfolio Compare Chart

140.49

P/E

3.22

D/E

-21.7%

ROE

-3.9%

ROA

0.00%

Div Yield

32.15

PEG

TRAVERE THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 45.20 Price 2.24 (5.21%) Day Change	NEWS SCORE: 85

TVTX มีคุณภาพโดยรวมยังไม่ดีนัก ( คะแนนปัจจัยพื้นฐาน = 54) แต่ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio ค่อนข้างสูง
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ไม่ดี สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร ยังไม่ดีนัก , ...

ปัจจัยทางคุณภาพ

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.08 From 30 days period
News Score	85
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	45.20
PBV / Sector	40.46 / 4.48
Earning Per Share	-0.24

PE / Sector	140.49 / 16.68
PEG or PE/Growth / Sector	32.15 / 0.53
Average 1M Daily Value	102.49 M GREAT
Average 1W Daily Value	83.57 M

ปัจจัยทางเทคนิค

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-4.00 / 450.37
NPM Average (%) / Sector	-95.64 / -1,506.30
NPM Change Average (%) / Sector	-27.39 / 4,941.44
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-3.86 / 30.83
ROA Average (%) / Sector	-23.55 / -347.12
ROA Change Average (%) / Sector	29.15 / 5,126.35 GREAT
ROE (%) / Sector	-21.70 / -3.04
ROE Average (%) / Sector	-258.72 / 40.76
ROE Change Average (%) / Sector	172.82 / 2,110.63 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-04 09:24:06
Symbol	TVTX
Name	TRAVERE THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	92.99 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	3,994.97 / 8,483.11

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 3611 Valley Centre Drive, San Diego, CA, United States, 92130

Phone: 888 969 7879

Website: https://travere.com

Employees: 497

Sector: Healthcare >> Biotechnology

Description: Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. Its clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase, a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a collaboration agreement with PharmaKrysto Limited for the pre-clinical activities associated with the cystinuria program. Travere Therapeutics, Inc. was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. The company is headquartered in San Diego, California.